Hospital OR staffing evolves with predictive analytics and cross-training to optimize surgical care amid workforce shortages and burnout.
Proceeds support the continued clinical development of TRB-061, a novel TNFR2 agonist designed to selectively activate regulatory T cells (“Tregs”) in inflammatory diseases affecting skin and other ...
Proceeds will support advancement of the Company's oral small molecule GLP-1 candidate and other novel cardiometabolic programs into clinical development BOULDER, Colo., March 31, 2026 /PRNewswire/ -- ...
Stocktwits on MSN
WHWK stock edges up after hours: Firm boosts pipeline of cancer drugs on the heels of capital raise
The company expects to file applications to begin human testing for several of the new programs within the next 12 to 24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results